Next, using the previously published histological ratio (VI) reflecting the balance between vulnerable plaque components (neutral lipids, CD68+ cells and hemorrhage) and fibrous repair-associated plaque components (collagen and alpha-actin+ cells)15,16 we showed that T2D individuals with high plaque vulnerability index were at significantly higher risk for future CV events. The gene discussed is CD68; the disease is type 2 diabetes mellitus.